Next Article in Journal
Exenatide Microspheres for Monthly Controlled-Release Aided by Magnesium Hydroxide
Next Article in Special Issue
Recent Progress in Lipid Nanoparticles for Cancer Theranostics: Opportunity and Challenges
Previous Article in Journal
The Novel Use of PVP K30 as Templating Agent in Production of Porous Lactose
Previous Article in Special Issue
Growth Inhibitory Effects of Ester Derivatives of Menahydroquinone-4, the Reduced Form of Vitamin K2(20), on All-Trans Retinoic Acid-Resistant HL60 Cell Line
 
 
Review

Article Versions Notes

Pharmaceutics 2021, 13(6), 815; https://doi.org/10.3390/pharmaceutics13060815
Action Date Notes Link
article pdf uploaded. 30 May 2021 07:43 CEST Version of Record https://www.mdpi.com/1999-4923/13/6/815/pdf-vor
article xml file uploaded 2 June 2021 03:00 CEST Original file -
article xml uploaded. 2 June 2021 03:00 CEST Update -
article pdf uploaded. 2 June 2021 03:00 CEST Updated version of record https://www.mdpi.com/1999-4923/13/6/815/pdf-vor
article html file updated 2 June 2021 03:01 CEST Original file -
article xml file uploaded 17 June 2021 03:18 CEST Update -
article xml uploaded. 17 June 2021 03:18 CEST Update https://www.mdpi.com/1999-4923/13/6/815/xml
article pdf uploaded. 17 June 2021 03:18 CEST Updated version of record https://www.mdpi.com/1999-4923/13/6/815/pdf
article html file updated 17 June 2021 03:19 CEST Update -
article html file updated 26 July 2022 22:04 CEST Update https://www.mdpi.com/1999-4923/13/6/815/html
Back to TopTop